URGN - UroGen Pharma Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.50
DETAILS
HIGH:
$45.00
LOW:
$40.00
MEDIAN:
$42.50
CONSENSUS:
$42.50
UPSIDE:
43.63%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 109.8 | 90.4 | 82.7 | 64.4 | 48.0 | 11.8 | 0.0 | 1.1 | 8.2 | 17.5 | 0 | 0 | 0 |
| Cost of Revenue | 12.4 | 8.9 | 9.4 | 7.7 | 5.2 | 1.0 | 0 | 1.8 | 0.6 | 0.0 | 0.1 | 0 | 0 |
| Gross Profit | 97.3 | 81.5 | 73.4 | 56.7 | 42.9 | 10.8 | 0.0 | (0.7) | 7.6 | 17.5 | (0.1) | 0 | 0 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 67.1 | 57.1 | 45.6 | 52.9 | 47.6 | 47.3 | 49.3 | 36.9 | 18.7 | 10.3 | 10.5 | 4.0 | 2.3 |
| SG&A Expenses | 155.1 | 0 | 93.3 | 82.8 | 0 | 90.2 | 60.2 | 39.6 | 8.8 | 6.4 | 1.9 | 0.9 | 1.1 |
| Other Expenses | 0 | 121.2 | 0 | 0 | 87.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 222.2 | 178.3 | 138.9 | 135.7 | 135.2 | 137.5 | 109.5 | 76.5 | 27.5 | 16.7 | 12.4 | 4.4 | 3.4 |
| Operating Income | |||||||||||||
| Operating Income | (124.9) | (96.8) | (65.5) | (79.0) | (92.3) | (126.7) | (109.5) | (77.2) | (19.9) | 0.8 | (12.4) | (4.4) | (3.4) |
| Interest Expense | 33.8 | 12.5 | 14.7 | 8.4 | 0 | 0.4 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 6.0 | 8.9 | 2.6 | 0.9 | 0.4 | 2.0 | 4.6 | 1.9 | 0.1 | 0.0 | 0 | 0.1 | 0.1 |
| Profitability | |||||||||||||
| EBITDA | (135.7) | (95.4) | (60.4) | (76.2) | (91.5) | (122.7) | (108.2) | (77.2) | (19.7) | 1.0 | (12.3) | (4.3) | (3.4) |
| EBIT | (138.1) | (95.7) | (62.1) | (78.0) | (92.3) | (124.8) | (109.5) | (77.2) | (19.9) | 0.8 | (12.4) | (4.4) | (3.4) |
| Income Before Tax | (153.4) | (124.0) | (98.3) | (108.0) | (109.4) | (125.1) | (105.1) | (75.5) | (20.0) | (1.9) | (12.7) | (4.5) | (3.3) |
| Income Tax Expense | 0.1 | 2.8 | 3.9 | 1.8 | 1.4 | 3.4 | 0 | 0.1 | 0.0 | 0 | 0 | 0 | 0 |
| Net Income | (153.5) | (126.9) | (102.2) | (109.8) | (110.8) | (128.5) | (105.1) | (75.7) | (20) | (1.9) | (12.7) | (4.6) | (3.3) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -3.19 | -2.96 | -3.55 | -4.79 | -4.96 | -5.90 | -4.90 | -4.80 | -2.06 | -0.16 | -5.51 | -1.98 | -1.56 |
| EPS (Diluted) | -3.19 | -2.96 | -3.55 | -4.79 | -4.96 | -5.90 | -4.90 | -4.80 | -2.06 | -0.16 | -5.51 | -1.98 | -1.56 |
| Shares Outstanding | 48.1 | 42.9 | 28.8 | 22.8 | 22.3 | 21.8 | 20.5 | 15.8 | 9.7 | 12.0 | 2.3 | 2.3 | 2.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 110.7 | 172.0 | 95.0 | 55.4 | 44.4 | 52.9 | 49.7 | 101.3 | 37.0 | 21.4 |
| Short-Term Investments | 9.7 | 64.7 | 42.0 | 44.6 | 44.8 | 49.2 | 97.4 | 0 | 36.0 | 0 |
| Net Receivables | 33.1 | 20.3 | 15.4 | 12.7 | 11.7 | 7.0 | 0 | 0 | 0 | 0.1 |
| Inventory | 16.5 | 9.2 | 5.7 | 4.3 | 4.8 | 2.0 | 0 | 0 | 0.3 | 0.1 |
| Other Current Assets | 16.0 | 9.9 | 11.1 | 11.9 | 1.2 | 1.2 | 0.5 | 0.3 | 0.2 | 0.1 |
| Total Current Assets | 186.0 | 276.1 | 169.2 | 128.9 | 114.4 | 115.6 | 148.6 | 102.2 | 74.5 | 22.0 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 9.1 | 3.8 | 2.4 | 3.7 | 3.1 | 4.2 | 4.7 | 0.9 | 0.8 | 0.7 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 5.0 | 4.5 | 0 | 0.7 | 1.9 | 48.6 | 0.1 | 0.0 | 0.0 |
| Other Non-Current Assets | 5.3 | 0.8 | 2.3 | 3.0 | 1.5 | 0.3 | 0.5 | 0.3 | 0.2 | 0.2 |
| Total Non-Current Assets | 14.4 | 9.6 | 9.1 | 6.7 | 5.4 | 6.4 | 53.8 | 1.3 | 1.1 | 1.0 |
| Total Assets | 200.5 | 285.7 | 178.3 | 135.6 | 119.7 | 122.0 | 202.4 | 103.6 | 75.5 | 23.1 |
| Current Liabilities | ||||||||||
| Account Payables | 12.1 | 10.9 | 6.5 | 5.5 | 5.8 | 3.3 | 4.7 | 4.3 | 2.8 | 1.9 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.7 | 0 |
| Other Current Liabilities | 34.3 | 18.5 | 14.7 | 11.5 | 10.3 | 11.4 | 1.6 | 0 | (1.6) | 0.6 |
| Total Current Liabilities | 46.4 | 45.9 | 31.2 | 23.9 | 22.4 | 21.4 | 19.5 | 13.5 | 7.0 | 3.1 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 122.2 | 121.7 | 98.6 | 97.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 3.0 | 2.8 | 2.7 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 131.2 | 125.2 | 112.9 | 98.9 | 85.7 | 0 | 0 | 0 | 0 | 3.6 |
| Total Non-Current Liabilities | 259.5 | 248.6 | 212.3 | 201.1 | 89.0 | 4.2 | 2.6 | 0 | 0 | 3.6 |
| Total Liabilities | 305.9 | 294.5 | 243.5 | 225.0 | 111.3 | 25.6 | 22.1 | 13.5 | 7.0 | 6.7 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (959.7) | (806.2) | (679.3) | (577.1) | (467.3) | (356.5) | (228.0) | (122.9) | (47.2) | (27.2) |
| Accumulated Other Comprehensive Income | 0.0 | 0.1 | 0.0 | (0.1) | (0.0) | 0.3 | 0.3 | (0.7) | (0.6) | (0.4) |
| Total Stockholders' Equity | (105.5) | (8.8) | (65.2) | (89.4) | 8.4 | 96.4 | 180.3 | 90.1 | 68.5 | 16.3 |
| Total Liabilities & Equity | 200.5 | 285.7 | 178.3 | 135.6 | 119.7 | 122.0 | 202.4 | 103.6 | 75.5 | 23.1 |
| Debt Metrics | ||||||||||
| Total Debt | 128.3 | 123.4 | 99.4 | 99.1 | 0.4 | 1.5 | 2.6 | 0 | 0 | 0 |
| Net Debt | 17.6 | (48.6) | 4.4 | 43.7 | (44.0) | (51.4) | (47.1) | (101.3) | (37.0) | (21.4) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (153.5) | (126.9) | (102.2) | (109.8) | (110.8) | (128.5) | (105.1) | (75.7) | (20) | (1.9) |
| Depreciation & Amortization | 2.4 | 1.2 | 1.7 | 1.8 | 1.8 | 2.0 | 1.3 | 0.4 | 0.2 | 0.2 |
| Stock-Based Compensation | 12.0 | 13.1 | 9.3 | 10.6 | 23.1 | 28.0 | 30.0 | 30.6 | 6.3 | 2.0 |
| Change in Working Capital | (27.9) | 4.9 | 3.3 | (6.3) | (13.1) | (6.4) | 4.3 | 7.2 | 3.8 | 1.2 |
| Other Non-Cash Items | 4.6 | 10.9 | 11.5 | 16.1 | (1.2) | (1.5) | (0.9) | 0.1 | 0.2 | 2.7 |
| Operating Cash Flow | (162.4) | (96.8) | (76.4) | (87.6) | (84.9) | (105.9) | (71.0) | (37.3) | (9.6) | 4.2 |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.3) | (0.3) | (0.2) | (0.3) | (0.8) | (1.2) | (0.3) | (0.6) | (0.3) | (0.7) |
| Acquisitions | 0 | 0 | 0 | (1.3) | (4.8) | (94.5) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (77.4) | (128.0) | (49.8) | (63.0) | (51.9) | (29.7) | (197.7) | (0.1) | (36.0) | (0.0) |
| Sales/Maturities of Investments | 139.2 | 107.7 | 49.1 | 64.3 | 56.7 | 124.1 | 52.6 | 35.9 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 1.3 | 4.8 | 94.5 | (0.2) | (0.1) | (0.1) | (0.1) |
| Investing Cash Flow | 61.6 | (20.6) | (1.0) | 1.1 | 4.1 | 93.2 | (145.6) | 35.3 | (36.4) | (0.8) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (1.9) | 24.5 | 0 | 95.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 19.0 | 49.6 | 0 | 72.4 | 0.7 | 3.6 | 2.2 | 0.7 | (0.0) |
| Financing Cash Flow | 39.9 | 194.6 | 116.9 | 97.1 | 72.3 | 16.5 | 165.2 | 66.4 | 61.6 | (0.0) |
| Cash Position | ||||||||||
| Net Change in Cash | (61.0) | 77.2 | 39.6 | 10.6 | (8.5) | 3.9 | (51.4) | 64.4 | 15.6 | 3.4 |
| Cash at Beginning | 173.1 | 95.8 | 56.2 | 45.6 | 54.1 | 50.2 | 101.6 | 37.2 | 21.4 | 18.0 |
| Cash at End | 112.1 | 173.1 | 95.8 | 56.2 | 45.6 | 54.1 | 50.2 | 101.6 | 37.0 | 21.4 |
| Free Cash Flow | (162.7) | (97.1) | (76.6) | (87.8) | (85.6) | (107.1) | (71.3) | (37.9) | (9.8) | 3.5 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 109.8 | 90.4 | 82.7 | 64.4 | 48.0 | 11.8 | 0.0 | 1.1 | 8.2 | 17.5 | 0 | 0 | 0 |
| Gross Profit | 97.3 | 81.5 | 73.4 | 56.7 | 42.9 | 10.8 | 0.0 | (0.7) | 7.6 | 17.5 | (0.1) | 0 | 0 |
| Operating Income | (124.9) | (96.8) | (65.5) | (79.0) | (92.3) | (126.7) | (109.5) | (77.2) | (19.9) | 0.8 | (12.4) | (4.4) | (3.4) |
| Net Income | (153.5) | (126.9) | (102.2) | (109.8) | (110.8) | (128.5) | (105.1) | (75.7) | (20) | (1.9) | (12.7) | (4.6) | (3.3) |
| EPS (Diluted) | -3.19 | -2.96 | -3.55 | -4.79 | -4.96 | -5.90 | -4.90 | -4.80 | -2.06 | -0.16 | -5.51 | -1.98 | -1.56 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 110.7 | 172.0 | 95.0 | 55.4 | 44.4 | 52.9 | 49.7 | 101.3 | 37.0 | 21.4 | |||
| Total Assets | 200.5 | 285.7 | 178.3 | 135.6 | 119.7 | 122.0 | 202.4 | 103.6 | 75.5 | 23.1 | |||
| Total Debt | 128.3 | 123.4 | 99.4 | 99.1 | 0.4 | 1.5 | 2.6 | 0 | 0 | 0 | |||
| Stockholders' Equity | (105.5) | (8.8) | (65.2) | (89.4) | 8.4 | 96.4 | 180.3 | 90.1 | 68.5 | 16.3 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (162.4) | (96.8) | (76.4) | (87.6) | (84.9) | (105.9) | (71.0) | (37.3) | (9.6) | 4.2 | |||
| Capital Expenditure | (0.3) | (0.3) | (0.2) | (0.3) | (0.8) | (1.2) | (0.3) | (0.6) | (0.3) | (0.7) | |||
| Free Cash Flow | (162.7) | (97.1) | (76.6) | (87.8) | (85.6) | (107.1) | (71.3) | (37.9) | (9.8) | 3.5 | |||